Palvella Therapeutics, Inc. announced on February 25, 2026, an underwriting agreement to issue 1,600,000 shares of common stock at $125.00 each, potentially raising about $187.3 million for their programs and working capital. The deal includes an option for underwriters to purchase 240,000 additional shares within 30 days.